Cytokine storm in COVID-19 research

Cytokine storm in COVID-19 research

Anatomy - Pathology / Cytogenetics

May 05, 2020

New research is rapidly accumulating around cytokine storms as a key biological response to SARS-CoV-2 infection. Get more information and learn about products associated with this process.
Click here to find out more.

BRCA Tumor MASTR Plus Product launch

BRCA Tumor MASTR Plus Product launch

Anatomy - Pathology / Cytogenetics

Multiplicom is pleased to announce the release of the BRCA Tumor MASTR Plus molecular assay, research use only, for identification of SNVs in the coding region of BRCA1 and BRCA2 in various types of solid tumors.

June 17, 2015 More +
Ready to make an enquiry Call us on: + 961 1 39 66 77
Or email us